Endothelin-2 (EDN2), expressed at a narrow window during the periovulatory period, critically affects ovulation and corpus luteum (CL) formation. LH (acting mainly via cAMP) and hypoxia are implicated in CL formation; therefore, we aimed to elucidate how these signals regulate using human primary (hGLCs) and immortalized (SVOG) granulosa-lutein cells. The hypoxiamiR, microRNA-210 (miR-210) was identified as a new essential player in expression. Hypoxia (either mimetic compound-CoCl, or low O) elevated hypoxia-inducible factor 1A (HIF1A), miR-210 and Hypoxia-induced miR-210 was suppressed in HIF1A-silenced SVOG cells, suggesting that miR-210 is HIF1A dependent. Elevated miR-210 levels in hypoxia or by miR-210 overexpression, increased Conversely, miR-210 inhibition reduced levels, even in the presence of CoCl, indicating the importance of miR-210 in the hypoxic induction of A molecule that destabilizes HIF1A protein, glycerol-3-phosphate dehydrogenase 1-like gene-, was established as a miR-210 target in both cell types. It was decreased by miR-210-mimic and was increased by miR-inhibitor. Furthermore, reducing by endogenously elevated miR-210 (in hypoxia), miR-210-mimic or by siRNA resulted in elevated HIF1A protein and levels, implying a vital role for in the hypoxic induction of Under normoxic conditions, forskolin (adenylyl cyclase activator) triggered changes typical of hypoxia. It elevated, and miR-210 while inhibiting Furthermore, HIF1A silencing greatly reduced forskolin's ability to elevate and miR-210. This study highlights the novel regulatory roles of miR-210 and its gene target, GPD1L, in hypoxia and cAMP-induced by human granulosa-lutein cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.